Mark L. Offerhaus
Algemeen Directeur bij Micreos BV
Profiel
Mark L.
Offerhaus founded Eco Investment Partners BV in 2005.
Mr. Offerhaus also founded Micreos BV, where he worked as Chief Executive Officer.
Mr. Offerhaus also formerly worked at Micreos Human Health BV, as Chief Executive Officer from 2005 to 2023, Exponential Biotherapies, Inc., as Director in 2004, ING Groep NV, as Principal, and Enuenu Life Insurance Co., Ltd., as President.
Mr. Offerhaus received his graduate degree from the University of Leiden.
Actieve functies van Mark L. Offerhaus
Bedrijven | Functie | Begin |
---|---|---|
Micreos BV
Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Algemeen Directeur | - |
Eco Investment Partners BV | Corporate Officer/Principal | 01-01-2005 |
Eerdere bekende functies van Mark L. Offerhaus
Bedrijven | Functie | Einde |
---|---|---|
Micreos Human Health BV
Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Algemeen Directeur | 01-06-2023 |
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-01-2004 |
ING GROEP N.V. | Corporate Officer/Principal | - |
Enuenu Life Insurance Co., Ltd.
Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | President | - |
Opleiding van Mark L. Offerhaus
University of Leiden | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ING GROEP N.V. | Finance |
Bedrijven in privébezit | 5 |
---|---|
Micreos BV
Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Health Technology |
Eco Investment Partners BV | |
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Health Technology |
Enuenu Life Insurance Co., Ltd.
Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | Finance |
Micreos Human Health BV
Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Health Technology |